FeesSafety
Pluang+

Park Dental Partners sets Q3 2026 earnings release for Nov 12, with a conference call on Nov 13.

Company Fundamentals
26 Oct 2026, 23:13 WIB
GlobeNewsWire
View Source
Neutral
Park Dental Partners sets Q3 2026 earnings release for Nov 12, with a conference call on Nov 13.

Park Dental Partners announced it will release its financial results for the third quarter ending September 30, 2026, after market close on November 12, 2026. The company will hold a conference call to discuss these results on November 13, 2026, at 8:30 a.m. Eastern Time. Investors can access the live webcast by registering online, with a replay available for a limited time. This update is important for stakeholders to assess the company's recent performance and outlook.

Park Dental Partners' upcoming Q3 2026 earnings release provides context for health sector activity on Pluang as of Oct 27, 2026 03:11 WIB. Among 150 health-sector US stocks, 80 rose and 70 fell. Summit Therapeutics Inc (SMMT) dropped 6.37% to USD 14.48 with balanced buy/sell orders and a typical hold time of 17 days, contrasting with Smith & Nephew plc (SNN) which gained 5.54% to USD 30.85 despite 100% sell orders and a longer hold time of 123 days. Tango Therapeutics Inc. (TNGX) fell 5.36% to USD 22.09 but had strong buy interest at 86% and a very short hold time of 2 days.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
2 hours ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App